Category Archives: Healthcare

Healthcare Press Releases & News distributed via EuropaWire

Evotec Biologics Unveils J.CHO™ High Expression System for Enhanced Antibody Production

(IN BRIEF) Evotec Biologics, the biologics arm of Evotec SE, has introduced its proprietary J.CHO™ High Expression System for antibody expression. J.CHO™ optimizes biotherapeutic production processes by providing higher productivity and quality for complex antibody formats. Engineered from Chinese hamster … Read the full press release

TUM-Led Study Reveals Impact of Infant Formula Composition on Gut Microbiota Development

(IN BRIEF) A study led by Prof. Dirk Haller from TUM involving 210 infants found that the composition of infant formula significantly influences the development of intestinal flora. While breast milk remains the gold standard, formula enriched with galacto-oligosaccharides led … Read the full press release

Breakthrough in Capacitor Technology Paves the Way for More Efficient Medical Devices and Electric Vehicles

(IN BRIEF) Researchers at the University of Twente have developed a groundbreaking design strategy to enhance the efficiency, storage capacity, and durability of capacitors used in critical applications like pacemakers, defibrillators, radar technology, and electric vehicles. Led by Dr. Minh … Read the full press release

Symrise Unveils Novel Health Solutions at Vitafoods Europe 2024

(IN BRIEF) Symrise is set to debut innovative health active solutions at Vitafoods Europe 2024, showcasing six concepts designed to address gut health, immunity, healthy aging, and metabolic health. The company’s focus on consumer needs drives the development of these … Read the full press release

Beiersdorf Unveils Breakthrough Anti-Glycation Ingredient to Combat Sugar-Induced Skin Aging

(IN BRIEF) After nearly a decade of research, Beiersdorf has revealed a groundbreaking discovery in skincare: a patented active ingredient called NAHP, also known as GLYCOSTOP™, designed to counteract the skin’s glycation process induced by sugar consumption, which contributes to … Read the full press release

Prudential Launches Climate & Health Resilience Fund to Address Climate Change Impacts

(IN BRIEF) Prudential plc, a prominent insurance company in Asia and Africa, has announced a significant investment of US$2.5 million through its community investment arm, Prudence Foundation, to tackle the effects of climate change on health and enhance climate resilience, … Read the full press release

Continental Survey Reveals Driver Attitudes Towards Health Checks and Advanced Safety Systems

(IN BRIEF) A recent survey commissioned by Continental highlights German drivers’ perspectives on health checks and advanced driver assistance systems (ADAS). Almost two-thirds of respondents consider regular health checks a sensible means to assess fitness for driving, with significant generational … Read the full press release

Philips Museum Launches Interactive AI Exhibition: brAInpower

(IN BRIEF) The Philips Museum in Eindhoven, Netherlands, is set to unveil its new exhibition, ‘brAInpower,’ on April 20th, focusing on artificial intelligence (AI) and its impact, particularly in healthcare. Through interactive elements, rare collection pieces, and informative videos, visitors … Read the full press release

Advancements in Causal Machine Learning Poised to Revolutionize Medical Diagnostics and Therapy, Researchers Say

(IN BRIEF) An international research group, led by Professor Stefan Feuerriegel from LMU, is pioneering the application of causal machine learning (ML) in medical diagnostics and therapy. Published in Nature Medicine, their study asserts that causal ML has the potential … Read the full press release

University of Liverpool Awarded £1.3m to Combat Antimicrobial Resistance in Fleming Fund Partner Countries

(IN BRIEF) The University of Liverpool has secured £1.3m in funding to support the UK Government’s Fleming Fund Fellowship Programme, aimed at addressing antimicrobial resistance (AMR) in partner countries. Led by Professor Alison Holmes, the program will provide mentorship and … Read the full press release

Sanofi’s Frexalimab Shows Promise in Phase 2 for Treating Multiple Sclerosis

(IN BRIEF) Sanofi’s experimental CD40L antibody, frexalimab, demonstrates encouraging results in a 48-week phase 2 study for relapsing multiple sclerosis (MS). Presented at the American Academy of Neurology Annual Meeting, the data reveals sustained reduction in disease activity and favorable … Read the full press release

Long-Term Study Shows Sustained Efficacy of Kesimpta in Treating Relapsing Multiple Sclerosis

(IN BRIEF) Novartis revealed promising data from the ALITHIOS open-label extension study, highlighting the enduring effectiveness of Kesimpta® (ofatumumab) in treating relapsing multiple sclerosis (RMS) over a span of up to six years. The study, presented at the American Academy … Read the full press release

AstraZeneca’s IMPACT CKD Model Forecasts Alarming Rise in Chronic Kidney Disease by 2032

(IN BRIEF) AstraZeneca’s IMPACT CKD model predicts a significant increase in chronic kidney disease (CKD) across eight countries, with up to 16.5% of the population affected by 2032, including a substantial rise in advanced-stage cases. Presented at the 2024 ISN … Read the full press release

Advancing Healthcare: Bosch and Randox Labs Partner to Revolutionize Molecular Diagnostics

(IN BRIEF) Bosch and Randox Laboratories Ltd. have forged a strategic partnership aimed at transforming molecular diagnostics with a focus on the Vivalytic analysis platform. With an investment of 150 million euros in joint research, development, and distribution, the collaboration … Read the full press release

EBRD Invests €22 Million to Propel Farmak’s Expansion into Polish Market

(IN BRIEF) The European Bank for Reconstruction and Development (EBRD) has provided a €22 million loan to Ukrainian pharmaceutical giant Farmak Group to facilitate its strategic acquisition of a Polish pharmaceutical company and to upgrade its IT systems. Farmak, a … Read the full press release

Philips Reaches Final Agreement on Consent Decree for Respironics Business with DOJ and FDA

(IN BRIEF) Royal Philips announces the final agreement on a consent decree for its subsidiary, Philips Respironics, with the US Department of Justice (DOJ) and the US Food and Drug Administration (FDA). The decree primarily focuses on Respironics’ US operations, … Read the full press release

Study Reveals High Rates of Repeat Antibiotic Prescriptions for Respiratory Tract Infections in UK Primary Care

(IN BRIEF) A recent study conducted by researchers from the Universities of Bristol and Bath, King’s College London, and University Medical Center Utrecht highlights the concerning prevalence of repeat antibiotic prescriptions for respiratory tract infections (RTIs) within the same episode … Read the full press release

Infant Brain Responses to Speech Predict Later Language Development, Study Finds

(IN BRIEF) A study conducted at the University of Helsinki under the DyslexiaBaby project reveals that infants’ neural responses to speech sounds can predict their later development of language and literacy skills. Stronger neural responses in the left side of … Read the full press release

Breakthrough Study: Single Genetic Test Offers Early Diagnosis for Children with Rare Disorders

(IN BRIEF) A groundbreaking study led by researchers from the University of Exeter, the Wellcome Sanger Institute, and the University of Cambridge introduces a novel approach to genetic testing, potentially revolutionizing the diagnosis of rare developmental disorders in children. By … Read the full press release

WACKER and Pantherna Collaborate to Ramp Up mRNA Production for ARDS Treatment

(IN BRIEF) WACKER’s mRNA competence center in Halle is gearing up to produce an active ingredient for combatting acute respiratory distress syndrome (ARDS) in collaboration with Pantherna Therapeutics. The center, equipped with four new production lines, will more than triple … Read the full press release

AstraZeneca’s Imfinzi Shows Promising Results in Phase III Trial for Small Cell Lung Cancer

(IN BRIEF) AstraZeneca announces positive outcomes from the ADRIATIC Phase III trial, revealing that its immunotherapy drug Imfinzi (durvalumab) demonstrated a significant improvement in overall survival (OS) and progression-free survival (PFS) among patients with limited-stage small cell lung cancer (LS-SCLC) … Read the full press release

EIB Provides €25 Million Financing to Wandercraft for Personal Exoskeleton Development

(IN BRIEF) French medtech company Wandercraft secures €25 million financing from the European Investment Bank (EIB) to advance the development of their groundbreaking Personal Exoskeleton. This innovative device, the first self-balancing exoskeleton designed for daily use by individuals with severe … Read the full press release

FDA Approves Basilea’s ZEVTERA® for Severe Bacterial Infections, Including Pediatric Use

(IN BRIEF) Basilea Pharmaceutica Ltd, a biopharmaceutical company, has received approval from the US Food and Drug Administration (FDA) for ZEVTERA® (ceftobiprole medocaril sodium for injection). The approval covers its use in adult patients with Staphylococcus aureus bloodstream infections (bacteremia), … Read the full press release

Unitaid Grants Additional Funding to University of Liverpool-led LONGEVITY Project for Long-Acting Infectious Disease Therapeutics

(IN BRIEF) Unitaid has allocated over £6 million in new funding to the University of Liverpool-led LONGEVITY project, aimed at enhancing long-acting therapeutics for tuberculosis, malaria, and hepatitis C. Started in 2020, the project has achieved preclinical milestones for long-acting … Read the full press release

CompuGroup Medical Welcomes New Digitization Experts to German Healthcare Sector

(IN BRIEF) CompuGroup Medical SE & Co. KGaA (CGM), a leading e-health provider, has announced the appointment of two renowned digitization experts in the German healthcare system. Max Müller has assumed leadership of the CLICKDOC & m.Doc business area, while … Read the full press release

Aviva Partners with Joe Wicks and Strava to Encourage Nationwide Wellbeing Revolution

(IN BRIEF) Aviva collaborates with fitness icon Joe Wicks and Strava to launch the #MoveWithAviva challenge, aiming to inspire individuals across the nation to prioritize their health and wellness. In response to findings revealing common barriers to exercise, such as … Read the full press release

University of Helsinki Launches Doctoral Researcher Positions Pilot Funded by Finnish Ministry

(IN BRIEF) The University of Helsinki has initiated a doctoral education pilot, sponsored by the Finnish Ministry of Education and Culture, offering three-year positions for doctoral researchers. With 236 vacancies across 11 sectoral pilots, the application period runs until April … Read the full press release

AstraZeneca and Daiichi Sankyo’s BLA for Datopotamab Deruxtecan Accepted by FDA for Advanced Breast Cancer Treatment

(IN BRIEF) AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been acknowledged by the US FDA for treating adult patients with unresectable or metastatic hormone receptor (HR)-positive, HER2-negative breast cancer who have received prior systemic … Read the full press release

AstraZeneca and Sanofi’s Beyfortus Receives Approval in Japan for Prophylaxis against Respiratory Syncytial Virus

(IN BRIEF) AstraZeneca and Sanofi celebrate the approval of Beyfortus (nirsevimab) in Japan by the Ministry of Health, Labour, and Welfare for preventing lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in neonates, infants, and children entering … Read the full press release

AstraZeneca’s Truqap Gets Green Light in Japan for Advanced Breast Cancer Treatment

(IN BRIEF) AstraZeneca announces the approval of Truqap (capivasertib) in combination with Faslodex (fulvestrant) by the Japanese Ministry of Health, Labour, and Welfare (MHLW) for treating adult patients with unresectable or recurrent hormone receptor-positive, HER2-negative breast cancer. The approval, based … Read the full press release

Sony Study Reveals Persisting Mental Health Challenges Among European Surgeons and Oncologists

(IN BRIEF) A recent survey conducted by Sony Healthcare Europe indicates that 95% of surgeons and oncologists across Europe experienced negative mental health issues in 2023, a level comparable to the aftermath of the pandemic in 2021. The survey of … Read the full press release

Study Reveals Higher Prevalence of Lewy Body Disease in Middle-Aged Population

(IN BRIEF) A recent study by the University of Helsinki and the University of Tampere suggests that Lewy body disease, the second most common brain degenerative disorder after Alzheimer’s, may be more prevalent in middle-aged individuals than previously believed. Utilizing … Read the full press release

Yrsa Daley-Ward Joins Sainsbury’s and Comic Relief to Amplify Voices of Food Club Members

(IN BRIEF) Poet Yrsa Daley-Ward collaborates with Sainsbury’s and Comic Relief to illuminate the untold struggles of individuals facing food insecurity in the UK. Through “Unspoken Words,” a collection of poems inspired by real-life stories from the Bonny Downs food … Read the full press release

Fraunhofer Showcases AI-Based Healthcare Innovations at DMEA 2024

(IN BRIEF) Fraunhofer experts are at the forefront of developing AI-driven systems to revolutionize healthcare, presenting their latest advancements at the DMEA 2024 trade show. These innovations span various areas, including diagnostics, surgery planning, telemedicine, and data management. From AI-based … Read the full press release

Mubadala Acquires KELIX bio, Expanding Access to Life-Saving Pharmaceuticals in Emerging Markets

(IN BRIEF) DPI, BII, and the EBRD have reached a binding agreement to fully exit their investment in KELIX bio, a pan-African biopharmaceutical platform, through its acquisition by Mubadala Investment Company. Founded in 2020, KELIX bio has rapidly grown to … Read the full press release

Novo Nordisk Acquires Cardior Pharmaceuticals in Billion-Euro Deal, Pioneering RNA Therapies for Heart Diseases

(IN BRIEF) EQT Life Sciences proudly announces Novo Nordisk’s acquisition of Cardior Pharmaceuticals, valuing the biopharmaceutical company at up to EUR 1.025 billion. Based in Hannover, Germany, Cardior specializes in RNA-based therapeutics for cardiovascular diseases, focusing initially on heart failure. … Read the full press release

Ultomiris Receives FDA Approval as First Long-Acting Treatment for AQP4 Ab+ NMOSD, Redefining Patient Care

(IN BRIEF) Ultomiris (ravulizumab-cwvz) has gained approval from the FDA as the inaugural long-acting C5 complement inhibitor for treating adult patients with anti-aquaporin-4 (AQP4) antibody-positive (Ab+) neuromyelitis optica spectrum disorder (NMOSD). The approval, based on the CHAMPION-NMOSD Phase III trial’s … Read the full press release

Annual Charity Netball Tournament Raises Over £32,000 for Look Good Feel Better Cancer Support Charity

(IN BRIEF) Look Good Feel Better, in partnership with England Netball, organized its Annual Charity Netball Tournament at the University of Warwick, raising over £32,000 for individuals undergoing cancer treatment. The event, attended by 240 netball players, featured 26 teams … Read the full press release

Breakthrough Blood Test May Revolutionize Tuberculosis Detection, Potentially Saving Millions of Lives

(IN BRIEF) Researchers at the University of Southampton have made significant progress towards developing a blood test capable of identifying millions of individuals unknowingly spreading tuberculosis (TB). By analyzing blood markers, the study identified a set of six proteins highly … Read the full press release

Understanding Women’s Sleep and Emotions Across the Menstrual Cycle: New Research Insights

(IN BRIEF) New research reveals that women experience disruptions in sleep patterns and heightened feelings of anger in the days leading up to their period, shedding light on the intricate relationship between menstrual cycles, emotions, and sleep. Conducted by the … Read the full press release